The Society for Participatory Medicine is pleased to announce that we will be partnering with the American College of Radiology to present an important topic in healthcare at the next Learning Exchange, which will take place on April 19, 2017, 2-3PM EST.  Join us as we share tips, data and best practices that can empower you to make informed decisions as you discuss and understand the relative benefits and costs of diagnostic imaging.  Pre-registration is required and you can sign up here. Please also spread the word, as this is open to the community!

Speakers

Matt Hawkins, MD, Pediatric Interventional Radiologist, Assistant Professor, Emory University School of Medicine

Sarah Krüg, Exec Director, Society for Participatory Medicine; CEO, CANCER101; Founder, Health Collaboratory

Emmy Ganos, PhD, Program Officer, Robert Wood Johnson Foundation

Jennifer Coleman, MHSA, FACHE, CMM, Executive Director, Grand Traverse Radiologists

Andrea Borondy Kitts, Lung Cancer & Patient Advocate, Consultant, Lahey Hospital & Medical Center, The University of Connecticut Health Center

What is the Learning Exchange?

We are each individually advancing the participatory medicine movement in our day-to-day lives and interfaces with healthcare and/or our work. Understanding the work we are conducting within our individual silos can help us learn from one another, allow us to build upon ideas, forge collaborations, provide a forum for feedback and suggestions, and hopefully avoid duplication of efforts. Helpful tips and best practices we’ve adopted as we navigate the healthcare system can also be beneficial to others. The SPM Learning Exchange is a forum launched in 2016 to help us learn from one another and capture the work underway within participatory medicine under one umbrella.  If you are interested in presenting your work, best practices or tips during a future learning exchange, please submit here. If you have any questions, please contact sarahkrug@cancer101.org

Sarah Krüg

Sarah Krüg is a researcher, innovator, and patient advocate, whose mission is to alleviate health disparities and amplify the voices of patients and caregivers across healthcare. She is CEO of CANCER101, a patient advocacy organization whose mission is to help patients and caregivers navigate the cancer journey and partner with their healthcare team to make informed decisions. Sarah is also the founder of the Health Collaboratory, an innovation hub focused on amplifying the voice of the patient and caregiver, and bridging the gaps in healthcare. She is the acting Executive Director and Past President of the Society for Participatory Medicine, and serves on the board of the National Organization of Rare Diseases. She previously held the position of Global Education Director at Pfizer, as well as patient advocacy relations, where she also established the Global Investigator Initiated Research Program. Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center.